These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 12049620

  • 1. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [Abstract] [Full Text] [Related]

  • 2. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [Abstract] [Full Text] [Related]

  • 3. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 4. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 6. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
    [Abstract] [Full Text] [Related]

  • 7. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J, Marie C, Mossiat C, Lecomte JM, Gros C, Schwartz JC.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [Abstract] [Full Text] [Related]

  • 8. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J, Pereira M, Castro A, Dias P, Azevedo A, Bettencourt P, Ferreira A.
    Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
    [Abstract] [Full Text] [Related]

  • 9. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Lewis LK, Yandle TG, Cooper GJ, Coy DH, Richards AM, Nicholls MG.
    Circulation; 1997 Sep 16; 96(6):1983-90. PubMed ID: 9323090
    [Abstract] [Full Text] [Related]

  • 10. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB, Davies RO, Ferguson RK.
    Fed Proc; 1984 Apr 16; 43(5):1314-21. PubMed ID: 6323221
    [Abstract] [Full Text] [Related]

  • 11. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A, Bettencourt P, Dias P, Pestana M, Serrão P, Soares-da-Silva P, Cerqueira-Gomes M.
    Clin Sci (Lond); 2001 May 16; 100(5):557-66. PubMed ID: 11294697
    [Abstract] [Full Text] [Related]

  • 12. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb 16; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 13. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J, Lalonde G, Bichet D, Rouleau JL.
    Can J Cardiol; 1990 Sep 16; 6(7):281-6. PubMed ID: 2121325
    [Abstract] [Full Text] [Related]

  • 14. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul 16; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 15. Direct cardiac and vascular actions of adrenomedullin in conscious sheep.
    Parkes DG, May CN.
    Br J Pharmacol; 1997 Mar 16; 120(6):1179-85. PubMed ID: 9134233
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic, hormonal, and renal actions of adrenomedullin 2 in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2008 Jul 16; 1(2):134-42. PubMed ID: 19808282
    [Abstract] [Full Text] [Related]

  • 17. Attenuated natriuretic response to adrenomedullin in experimental heart failure.
    Jougasaki M, Heublein DM, Sandberg SM, Burnett JC.
    J Card Fail; 2001 Mar 16; 7(1):75-83. PubMed ID: 11264553
    [Abstract] [Full Text] [Related]

  • 18. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM, Kramer BL, Topic N.
    Herz; 1983 Apr 16; 8(2):71-80. PubMed ID: 6343210
    [Abstract] [Full Text] [Related]

  • 19. Role of the renal nerves and angiotensin II in the renal function curve.
    Golin R, Genovesi S, Castoldi G, Wijnmaalen P, Protasoni G, Zanchetti A, Stella A.
    Arch Ital Biol; 1999 Aug 16; 137(4):289-97. PubMed ID: 10443320
    [Abstract] [Full Text] [Related]

  • 20. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
    Trippodo NC, Fox M, Natarajan V, Panchal BC, Dorso CR, Asaad MM.
    J Pharmacol Exp Ther; 1993 Oct 16; 267(1):108-16. PubMed ID: 8229737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.